Noom
Low-cost & Needle-free: Found Adds Oral Weight Loss Tablets
Found has launched affordable oral weight loss pills, but a groundbreaking drug-free solution is on the horizon from biomed company Epitomee.
WeightWatchers Retools with AI, Dietitians and ZeroPoint Potatoes
WeightWatchers is making potatoes OK again as the storied weight management company leans into compounded GLP-1s, AI and B2B.
Noom Adds $29 Oral Weight Loss Med Dubbed a “Miracle Drug”
Digital healthcare platform Noom is launching oral weight loss medication, beginning with FDA-approved Metformin.
The Business of GLP-1s: Inside the New Weight Loss Drug Ecosystem
As GLP-1 drugs surge, here's how telehealth companies and brick-and-mortar fitness giants are responding to the Ozempic era.
Noom Adds Body Scan Tech for GLP-1 Users
Noom has partnered with Prism Labs to give GLP-1 users a way to monitor and track body composition and muscle mass.
New Data Reveals Key Insights to Help Personal Trainers, Gyms
The rising interest in fitness and health has led gym membership and engagement numbers to soar across low-priced, high-value franchises
Zumba, Noom Partner on Fitness Content, Instructor Coaching
Zumba instructors can gain an edge by becoming Noom Mindset Coaches as the dance-fitness brand continues to expand its reach.
Can Fitness Programs Help Ozempic Users Keep Their Muscle?
A new market has emerged which focuses on maintaining the lean muscle mass of consumers taking weight-loss drugs like Ozempic.
Noom Names Geoff Cook CEO as it Enters Weight Loss Meds Sector
Noom co-founder Saeju Jeong will continue as the wellness company's executive chairman of the board after serving as CEO for 16 years.
Noom reaches $56M Class Action Settlement
In a note on Noom’s blog, co-founders Saeju Jeong and Artem Petakov addressed the class action settlement and wrote...
